Author

admin

Browsing

Mike Huckabee, President Donald Trump’s nominee for U.S. ambassador to Israel, cleared a key hurdle Tuesday after the Senate voted to end debate on his nomination.

The Senate voted 53 to 46 to advance Hucakbee’s nomination. He now awaits a final confirmation vote as Israel continues its war against Hamas in the Gaza Strip.

While Republicans have championed Huckabee as an ardent supporter of Israel, Democrats have questioned his previous ‘extreme’ position on Palestinians.

The former Arkansas governor has previously argued it is Israel’s right to annex the West Bank and has flatly rejected the push to establish a two-state solution when it comes to the Gaza Strip. 

Huckabee has not commented on whether he still views the West Bank as Israel’s right to claim, or where he stands when it comes to Trump’s position on the Gaza Strip, which the president said he would like to turn into the ‘riviera of the Middle East’ and called for the ‘relocation’ of more than 2 million Palestinians.

During his confirmation hearing, the former governor pushed back on claims that Trump wants to take over the Gaza Strip, insisting the president has not called for the ‘forced displacement’ of Palestinians from Gaza – ‘unless it is for their safety.’

‘If confirmed, it will be my responsibility to carry out the president’s priorities, not mine,’ Huckabee said in response to questions levied at him from Sen. Jeff Merkley, D-Ore.

But Huckabee’s testimony during Senate questioning is unlikely to have garnered much new support from Democrats in Congress. 

‘Huckabee’s positions are not the words of a thoughtful diplomat – they are the words of a provocateur whose views are far outside international consensus and contrary to the core bipartisan principles of American diplomacy,’ New York Rep. Jerry Nadler, a senior Jewish Democrat, said in a statement last month. ‘In one of the most volatile and violent areas in the world today, there is no need for more extremism, and certainly not from the historic ambassador’s post and behind the powerful seal of the United States.’

The Associated Press contributed to this report. 

This post appeared first on FOX NEWS

House Republicans are divided over how to proceed on a massive piece of legislation aimed at advancing President Donald Trump’s agenda as a possible vote on the measure looms Wednesday afternoon.

Fiscal hawks are rebelling against GOP leaders over plans to pass the Senate’s version of a sweeping framework that sets the stage for a Trump policy overhaul on the border, energy, defense and taxes.

Their main concern has been the difference between the Senate and House’s required spending cuts, which conservatives want to offset the cost of the new policies and as an attempt to reduce the national deficit. The Senate’s plan calls for a minimum of $4 billion in cuts, while the House’s floor is much higher at $1.5 trillion.

‘The problem is, I think a lot of people don’t trust the Senate and what their intentions are, and that they’ll mislead the president and that we won’t get done what we need to get done,’ Rep. Rich McCormick, R-Ga., told reporters on Tuesday. ‘I’m a ‘no’ until we figure out how to get enough votes to pass it.’

McCormick said there were as many as 40 GOP lawmakers who were undecided or opposed to the measure.

A meeting with a select group of holdouts at the White House on Tuesday appeared to budge a few people, but many conservatives signaled they were largely unmoved.

‘I wouldn’t put it on the floor,’ Rep. Chip Roy, R-Texas, told reporters after the White House meeting. ‘I’ve got a bill in front of me, and it’s a budget, and that budget, in my opinion, will increase the deficit, and I didn’t come here to do that.’

Senate GOP leaders praised the bill as a victory for Trump’s agenda when it passed the upper chamber in the early hours of Saturday morning.

Trump urged all House Republicans to support it in a Truth Social post on Monday evening.

Meanwhile, House Republican leaders like Speaker Mike Johnson, R-La., have appealed to conservatives by arguing that passing the Senate version does not in any way impede the House from moving ahead with its steeper cuts.

The House passed its framework in late February.

Congressional Republicans are working on a massive piece of legislation that Trump has dubbed ‘one big, beautiful bill’ to advance his agenda on border security, defense, energy and taxes.

Such a measure is largely only possible via the budget reconciliation process. Traditionally used when one party controls all three branches of government, reconciliation lowers the Senate’s threshold for passage of certain fiscal measures from 60 votes to 51. As a result, it has been used to pass broad policy changes in one or two massive pieces of legislation.

Passing frameworks in the House and Senate, which largely only include numbers indicating increases or decreases in funding, allows each chamber’s committees to then craft policy in line with those numbers under their specific jurisdictions. 

Members of the conservative House Freedom Caucus have pushed for Johnson to allow the House GOP to simply begin crafting its bill without passing the Senate version, though both chambers will need to eventually pass identical bills to send to Trump’s desk.

‘Trump wants to reduce the interest rates. Trump wants to lower the deficits. The only way to accomplish those is to reduce spending. And $4 billion is not – that’s … anemic. That is really a joke,’ Rep. Eric Burlison, R-Mo., told reporters.

He said ‘there’s no way’ the legislation would pass the House this week.

The measure will likely go through the House Rules Committee, which acts as the final gatekeeper for most legislation getting a chamber-wide vote.

However, tentative plans for a late-afternoon House Rules Committee meeting on the framework, which would have set up a Wednesday vote, were scrapped by early evening on Tuesday.

The legislation could still get a House-wide vote late on Wednesday if the committee meets in the morning.

As for the House speaker, he was optimistic returning from the White House meeting on Tuesday afternoon.

‘Great meeting. The president was very helpful and engaged, and we had a lot of members whose questions were answered,’ Johnson told reporters. ‘I think we’ll be moving forward this week.’

Fox News’ Ryan Schmelz and Aishah Hasnie contributed to this report.

This post appeared first on FOX NEWS

Wall Street rebounded into the green as multiple foreign countries came to the tariff negotiating table with President Donald Trump – but that was not enough to assuage some lawmakers’ critiques of the ‘alla prima’ tariff actions, as one Republican put it.

U.S. Trade Representative Jamieson Greer testified Tuesday the U.S. has long-suffered from ‘China Shock’ – the surge in manufacturing outputs from the Communist nation since the turn of the century – and that the U.S. had to do something substantive but strategic about the 5 million manufacturing jobs lost and 90,000 factories closed since the middle of the Clinton administration.

‘President Biden left us with a $1.2 trillion trade deficit-in-goods – the largest of any country in the history of the world,’ Greer said.

‘During COVID, we were unable to procure semiconductors to build our cars or materials for pharmaceuticals and personal protective equipment. During World War II, we built nearly 9,000 ships. Last year, the United States built only three ocean-going vessels,’ he said.

Greer said the U.S. historically was on the surplus side of agriculture trade but that, as of late, purportedly friendly countries like Australia have essentially rejected beef and pork exports, while America has not reciprocated with their livestock.

That became a sore subject during a particularly heated exchange between Greer and Sen. Mark Warner, D-Va., as the lawmaker claimed Trump unnecessarily ‘clobbered’ Canberra with a 10% tariff.

‘We have a free trade agreement with Australia,’ he said, questioning Trump’s ‘fancy Greek formula’ for determining tariffs.

Democrats and media figures previously mocked Trump for tariffing uninhabited Australian islands in the Indian Ocean – which Commerce Secretary Howard Lutnick suggested over the weekend was to close any potential loophole to circumvent tariffs on such countries’ mainland.

Greer argued the ‘lowest rate available’ was imposed on Australia, leading Warner to ask again ‘why did they get whacked in the first place.’

‘Despite the [free trade] agreement, they ban our beef, they banned our pork, they’re getting ready to impose measures on our digital companies – It’s incredible,’ Greer said.

Warner later acknowledged markets had rebounded a ‘blip’ by midday but said a Wall Street contact equated it to a ‘good day in hospice.’

Meanwhile, during his opening remarks, Senate Finance Committee ranking member Ron Wyden said he has drafted a bipartisan resolution to ‘end the latest crop of global tariffs that are clobbering American families and small businesses.’

‘Members on both sides of the aisle ought to know that this is a call to action and Congress must step in to rein this president on trade,’ Wyden said.

He called the tariffs ‘aimless’ and ‘chaotic’ and said it showed Congress ceded the executive branch too much constitutional power.

In his testimony, Greer called trade imbalance an indicator of both an economic and national security emergency.

He also suggested America’s allies have been foisting unfair policies on the American consumer – including the European Union.

‘[They] can sell us all the shellfish they want, but the EU bans shellfish from 48 states. The result is a trade deficit in shellfish with the EU,’ he said.

‘We only charge a 2.5% tariff on ethanol, but Brazil charges us an 18% tariff. The result? We have a large trade deficit in ethanol with Brazil.’

‘Our average tariff on agricultural goods is 5%, but India’s average tariff is 39%. You understand the trend here.’

In response to some of Wyden’s concerns, Greer said Vietnam has already negotiated a lower tariff on U.S. cherries and apples exported from Oregon and the Northwest.

‘This is exactly the right direction that we want to go in,’ Greer said.

Sen. Bernie Sanders, I-Vt., struck a more middling tone on tariffs, saying that he has never been a ‘great fan of free trade,’ and cited his work ending NAFTA and opposing normalized relations with China.

He also cited the outsourcing of manufacturing to Mexico, saying it killed hundreds of thousands of American jobs and has many Mexican workers ‘living in cardboard boxes.’

‘That is the type of trade policy which I detest. But I want to move to an area, to talk about the legal basis of what President Trump has done,’ he said.

Sanders said he lives 50 miles from Canada and does not see the same empirical data on illegal immigration and fentanyl smuggling that Trump accused Ottawa of failing to act on – and incorporated into his tariff calculations.

On the Republican side, Chairman Michael Crapo, R-Idaho, was largely deferential to Trump and Greer, while some other Republicans voiced concerns.

Sen. Charles Grassley of Iowa questioned whether Congress ‘delegated too much authority to the president’ but said he supports the president so long as his mission is to ‘turn tariffs into trade deals to reduce tariff and non-tariff barriers’ versus any plot to ‘feed the U.S. Treasury through them.’

‘I made very clear throughout my public service that I’m a free and fair trader. The Constitution gives Congress the authority to regulate interstate and foreign commerce. I believe that Congress delegated too much authority to the president in the Trade Expansion Act of 1962 and Trade Act of 1974,’ he said.

Additionally, Sen. Thom Tillis, R-N.C., pressed Greer on who should be considered the person that will take ultimately responsibility for either praise or accountability depending on the outcome of the tariff actions.

‘Whose throat do I have to choke,’ he said, underlining that the phrase was borrowed from a management consulting mantra.

This post appeared first on FOX NEWS

Oded Lifshitz was 83 years old when he was ripped from his home in Kibbutz Nir Oz along with his wife, Yocheved, during Hamas’ attacks against Israel on Oct. 7, 2023. Yocheved returned to Israel alive in October 2023 and has been advocating for other hostages’ release ever since. On Feb. 20, 2025, Oded returned to Israel in a coffin. His family, however, has not given up hope for those who remain in Gaza.

Daniel Lifshitz, Oded and Yocheved’s grandson, told Fox News Digital that, while the hostages who have returned have brought some light back to Kibbutz Nir Oz, nothing can really be done until all the hostages are back. As of the time of this writing, 13 hostages taken from Nir Oz are still in Gaza, and not all of them are alive.

When speaking to Fox News Digital, Daniel described his late grandfather as a ‘warrior of peace,’ explaining that while Oded served in four wars, he also fought for the rights of minorities.

Oded and Yocheved were peace activists who helped Palestinian pediatric cancer patients from Gaza cross into Israel for chemotherapy. In the eulogy she delivered at her husband’s funeral, Yocheved discussed their activism and said they ‘were hit by a terrible attack by those we helped on the other side,’ according to the Times of Israel’s translation.

Daniel explained that his grandmother felt betrayed not by Hamas or Islamic Jihad, but by Palestinian civilians who she and her husband had spent years helping. 

‘After October 7, they didn’t — we didn’t see the Palestinians going to protest outside against Hamas, going to protests for the release of the hostages, which they know if they would release all the hostage is that will be also the end of the war,’ Daniel told Fox News Digital. ‘And they need to show that they don’t want Hamas, and that is where my grandmother she feels really great betrayal because it’s for whom we try.’

Oded’s body was returned alongside those of Ariel and Kfir Bibas. The boys’ mother, Shiri Bibas, was supposed to be in the fourth coffin, but her remains were not there when the coffin arrived in Israel. Her body was returned two days later.

‘… their return together is symbolizing the failure of the international community for me because in those cars came a 9-month-old baby, the only baby held hostage in the world with an 83-year-old great-grandfather, the only great-grandfather health hostage world,’ Daniel told Fox News Digital. 

Daniel grew up with Shiri’s sister, Dana, who told Fox News Digital that she is like a sister to him.
When asked about the differences between the Biden administration and the Trump administration’s handling of the situation, Daniel told Fox News Digital that Trump’s team is ‘more creative.’

‘If one thing doesn’t work, they don’t continue. They try to bring another solution,’ Daniel told Fox News Digital.

In the face of tragedy, the Lifshitz family has refused to give up hope that the remaining hostages, alive and dead, will one day return home to Israel. Daniel also hopes his grandmother will be able to get some rest once she knows the hostages are home.

This post appeared first on FOX NEWS

Vice President JD Vance spoke out against Sen. Mitch McConnell’s, R-Ky., vote against confirming Elbridge Colby to serve as undersecretary of defense for policy.

‘Mitch’s vote today—like so much of the last few years of his career—is one of the great acts of political pettiness I’ve ever seen,’ Vance declared in a post on X.

Colby was confirmed in a 54-45 vote on Tuesday. McConnell was the only Senate Republican to vote against confirmation, while three Democrats voted in Colby’s favor.

President Donald Trump announced Colby as his pick for the Pentagon post when he was the president-elect.

‘Elbridge Colby’s long public record suggests a willingness to discount the complexity of the challenges facing America, the critical value of our allies and partners, and the urgent need to invest in hard power to preserve American primacy,’ McConnell said in a statement.

‘The prioritization that Mr. Colby argues is fresh, new, and urgently needed is, in fact, a return to an Obama-era conception of a la carte geostrategy. Abandoning Ukraine and Europe and downplaying the Middle East to prioritize the Indo-Pacific is not a clever geopolitical chess move. It is geostrategic self-harm that emboldens our adversaries and drives wedges between America and our allies for them to exploit,’ the senator asserted.

McConnell has voted against multiple Trump nominees this year.

‘Mr. Colby’s confirmation leaves open the door for the less-polished standard-bearers of restraint and retrenchment at the Pentagon to do irreparable damage to the system of alliances and partnerships which serve as force multipliers to U.S. leadership. It encourages isolationist perversions of peace through strength to continue apace at the highest levels of Administration policymaking,’ McConnell said.

Vance spoke out in support of Colby last month at a Senate Armed Services Committee hearing on Colby’s nomination.

This post appeared first on FOX NEWS

Today’s pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 vaccines and global stock market upheaval.

However, the industry’s major underlying drivers — higher rates of cancer and chronic disease — are still at play and not expected to dissipate.

The US reigns supreme in the pharma market, both in terms of drug demand and development. In 2024, 50 novel medicines were approved by the US Food and Drug Administration (FDA), compared to 55 such approvals in 2023. Last year’s FDA approvals include Eli Lilly and Company’s (NYSE:LLY) Alzheimer’s disease treatment Kisunla.

Big pharma largely steals the show, but some small- and mid-cap NASDAQ pharma stocks have also made gains.

Read on to learn more about their activities this year.

1. DBV Technologies (NASDAQ:DBVT)

Year-to-date gain: 126.14 percent
Market cap: US$141.58 million
Share price: US$7.44

Headquartered in France, DBV Technologies is a clinical-stage biopharma developing treatment for immunologic conditions, such as food allergies, with unmet medical need. Its North American operations are based in New Jersey. Using its proprietary epicutaneous immunotherapy technology platform, Viaskin, the company is developing non-invasive transdermal treatments for food allergies with reactions of mild to life-threatening anaphylaxis.

DBV currently has a number of key food allergy programs in its clinical trial pipeline, including its Viaskin peanut patch, which is being tested in three Phase 3 clinical trials for different age groups: children ages one to three, children ages four to seven and children ages seven to 11. The company is also in Phase 2 testing for its Viaskin milk patch in children ages two to 17.

DBV’s stock experienced its first boost in early January after the company shared positive three year results from its open-label extension Phase 3 trial of the Viaskin peanut patch in toddlers on January 8. The results demonstrated further improvements in efficacy after 36 months of treatment. Shares in DBV jumped nearly 56 percent to US$5.41 on January 10.

The next big boost for DBV shares came in late March with two important developments. First, on March 24, the company announced that it had secured an agreement with the FDA on the safety exposure data required for the biologics license application for its Viaskin peanut patch for four to seven year-olds. This will accelerate the timeline for a BLA filing submission, which DBV now expects in H1 2026.

Next, on March 27, DBV launched a financing of up to US$306.9 million to advance its Viaskin peanut patch product for four to seven year-olds through the BLA submission and the potential commercialization of the product in the United States.

DBV Technologies’ share price hit a year-to-date high of US$7.86 on April 3.

2. Journey Medical (NASDAQ:DERM)

Year-to-date gain: 75.76 percent
Market cap: US$160.81 million
Share price: US$6.96

Journey Medical is a commercial-stage pharma company with a growing portfolio of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions. The company’s growth model focuses on acquisitions, out-licensing and in-licensing opportunities. Its portfoluo currently has eight products targeting skin conditions, including Accutane for acne, Zilxi for rosacea and Qbrexza for hyperhidrosis.

In the first quarter of 2025, Journey Medical completed the commercial launch of the FDA-approved Emrosi, a prescription drug for the treatment of rosacea in adults. Emrosi has shown head-to-head superiority in efficacy over Oracea, the current market leader. Journey Medical expects Emrosi to be a significant driver of revenue growth and earnings for the company going forward.

Journey Medical’s stock saw its first big gains in early February in anticipation of the commercial launch of Emrosi, with its share price rising 45 percent to US$5.35. The product officially hit the US market on March 24, and shares in Journey Medical reached a year-to-date high of US$7.19 on April 4.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Year-to-date gain: 68.44 percent
Market cap: US$57.41 million
Share price: US$4.11

Cumberland Pharmaceuticals is a Tennessee-based biopharma which develops, acquires and commercializes products for hospital acute care, gastroenterology and oncology markets. The company currently has a portfolio of six FDA-approved brands, including Sancuso for the prevention of nausea and vomiting in chemotherapy patients and Vibativ for the treatment of serious hospital-acquired bacterial infections and ventilator-associated bacterial pneumonia.

Cumberland’s clinical pipeline includes Dyscorban, an oral capsule in Phase 2 trials for the treatment of the cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The FDA has granted the drug candidate both orphan drug designation and rare pediatric disease designation for this indication.

Shares in Cumberland soared by 150 percent to US$5.34 on February 6, following the company’s February 4 release of positive top-line results from its Phase 2 FIGHT DMD trial.

‘These results represent a significant milestone in DMD cardiomyopathy,’ the trial’s principal investigator Dr. Larry W. Markham said. ‘We are seeing evidence that there is an opportunity to potentially alter the course of heart disease in DMD patients.”

The next jolt to Cumberland’s stock came on February 19, pushing the value to US$6.19 per share following the announcement that Vibativ had garnered approval from China’s pharmaceutical regulatory authority.

Cumberland Pharmaceuticals’ share price hit a year-to-date high of US$6.77 on March 5, after the company posted net revenues of US$10.4 million during the fourth quarter of 2024. That figure represents an 11.6 percent increase in net revenues over the prior year period.

4. Nuvectis Pharma (NASDAQ:NVCT)

Year-to-date gain: 51.19 percent
Market cap: US$192.75 million
Share price: US$8.24

Nuvectis Pharma is developing precision medicines targeting unmet needs in oncology. The company has two clinical-stage drug candidates in its pipeline: NXP800 and NXP900.

NXP800 is an oral small molecule GCN2 kinase activator currently in a Phase 1b clinical trial for ovarian cancer and in an Investigator-sponsored clinical trial for the treatment of bile duct cancer. NXP800 has an orphan drug designation from the FDA. Updated Phase 1b results are anticipated for release in Q2 2025.

NXP900 is an oral small molecule inhibitor of the Src family of kinases, which play a crucial role in cancer development and progression. The drug candidate is undergoing a Phase 1a dose escalation study, with a Phase 1b program expected to begin in mid-2025.

Nuvectis closed on a public offering of US$15.5 million on February 7, allowing it to fund the advancement of its development programs through 2027.

Shares in Nuvectis Pharma reached a year-to-date high of US$10.46 on March 28.

5. OptiNose (NASDAQ:OPTN)

Year-to-date gain: 33.63 percent
Market cap: US$92.16 million
Share price: US$9.10

Optinose specializes in the field of ear, nose, and throat (ENT) medicine targeting therapeutic areas such as allergies, chronic rhinosinusitis, nasal polyps, and chronic sinusitis. Its products include the FDA-approved Xhance (fluticasone propionate) and Onzetra Xsail (sumatriptan nasal powder), the latter of which is licensed to private company Currax Pharmaceuticals.

After starting out the year at US$6.70 per share, Optinose stock shot up to its year-to-date high of US$9.15 per share on March 20.

This followed news on March 19 that Massachusetts-based private firm Paratek Pharmaceuticals had inked a potential US$330 million definitive merger agreement to acquire Optinose, “with consideration payable to shareholders of up to US$14 per share, including the payment of contingent value rights (CVRs) tied to future commercial milestones.”

The following week, Optinose released its fourth quarter and full-year 2024 financials, highlighting Xhance net revenue of US$22.4 million for the quarter and US$78.2 million for the year, up 13 percent and 10 percent, respectively, compared to prior year periods. The company also reported 23 percent growth in prescriptions from the third quarter 2024 to fourth quarter 2024.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Strong demand in the face of looming supply shortages has pushed copper to new heights in recent years.

With a wide range of applications in nearly every sector, copper is by far the most industrious of the base metals. In fact, for decades, the copper price has been a key indicator of global economic health, earning the red metal the moniker “Dr. Copper.” Rising prices tend to signal a strong global economy, while a significant longer-term drop in the price of copper is often a symptom of economic instability.

After bottoming out at US$2.17 per pound, or US$5,203.58 per metric ton, in mid-March 2020, copper has largely been on an upward trajectory.

Why is copper so expensive in 2025? Higher copper prices over the past few years have largely been attributed to a widening supply/demand gap. The already tenuous copper supply picture was made worse by COVID-19 lockdowns, and as the world’s largest economies seemingly began to emerge from the pandemic, demand for the metal picked up once again. Copper mining and refining activities simply haven’t kept up with the rebound in economic activity.

In this article

    What key factors drive the price of copper?

    Robust demand has long been one of the strongest factors driving copper prices. The ever-growing number of copper uses in everyday life — from building construction and electrical grids to electronic products and home appliances — make it the world’s third most-consumed metal.

    Copper’s anti-corrosive and highly conductive properties are why it’s the go-to metal for the construction industry, and it’s used in products such as copper pipes and copper wiring. In fact, construction is responsible for nearly half of global copper consumption. Rising demand for new homes and home renovations in both Asian and Western economies is expected to support copper prices in the long term.

    In recent decades, copper price spikes have been strongly tied to rising demand from China as the economic powerhouse injects government-backed funding into new housing and infrastructure. Industrial production and construction activity in the Asian nation have been like rocket fuel for copper prices.

    Additionally, copper’s conductive properties are increasingly being sought after for use in renewable energy applications, including thermal, hydro, wind and solar energy.

    However, the biggest driver of copper consumption in the renewable energy sector is rising global demand for electric vehicles (EVs), EV charging infrastructure and energy storage applications. As governments push forward with transportation network electrification and energy storage initiatives as a means to combat climate change, copper demand from this segment is expected to surge.

    In 2024, EV sales worldwide increased by 25 percent over 2023 to come in at about 17.1 million units, and analysts at Rho Motion expect that trend to continue in the coming years despite some headwinds in the near-term. Already in the first two months of 2025, EV sales were up 30 percent over the same period in the previous year. New energy vehicles use significantly more copper than internal combustion engine vehicles, which only contain about 22 kilograms of copper. In comparison, hybrid EVs use an average of 40 kilograms, plug-in hybrid EVs use 55 kilograms, battery EVs use 80 kilograms and battery electric buses use 253 kilograms.

    On the supply side of the copper market, the world’s largest copper mines are facing depleting high-grade copper resources, while over the last decade or more new copper discoveries have become few and far between.

    The pandemic made the situation worse as mining activities in several top copper-producing countries faced work stoppages and copper companies delayed investments in further exploration and development — a challenging problem considering it can take as many as 10 to 20 years to move a project from discovery to production. In addition, delayed investments amid the pandemic will also have long-term repercussions for copper supply.

    There have also been ongoing production issues at major copper mines, most notably the shutdown in late 2023 of First Quantum Minerals’ (TSX:FM,OTC Pink:FQVLF) Cobre Panama mine, which accounted for about 350,000 MT of the world’s annual copper production.

    Citi analyst Max Layton projected in April 2024 that copper demand will outstrip supply by 1 million MT over the next three years, leading to a bull market for the red metal. ‘Explosive price upside is possible over the next two to three years,’ he noted.

    The supply shortage has increased the need for end users to turn to the copper scrap market to make up for the supply shortage. Sometimes referred to as “the world’s largest copper mine,” recycled copper scrap contributes significantly to supplying and balancing the copper market.

    “We are seeing signs this could change. Much of the growth over the last five years has come from brownfield expansions rather than greenfield/new discoveries,’ she said. ‘Technology will likely help increase the chance of discovery, and broadly I would say that policymakers are now more supportive of mineral exploration as the push to secure critical raw materials supply has moved up the agenda.’

    Joannides offered some examples of greenfield projects in the pipeline: Capstone Copper’s (TSX:CS,OTC Pink:CSCCF) Santo Domingo in Chile, Southern Copper’s (NYSE:SCCO) Tia Maria in Peru and Teck Resources’ (TSX:TECK.A,TECK.B,NYSE:TECK) Zafranal in Peru.

    How has the copper price moved historically?

    Taking a look back at historical price action, the copper price has had a wild ride for more than two decades.

    Sitting at US$1.38 per pound in late January 2005, the copper price followed global economic growth up to a high of US$3.91 in April 2008. Of course, the global economic crisis of 2008 soon led to a copper crash that left the metal at only US$1.29 by the end of year.

    Once the global economy began to recover in 2011, copper prices posted a new record high of US$4.58 per pound at the start of the year. However, this high was short-lived as the copper price began a five year downward trend, bottoming out at around US$1.95 in early 2016.

    Copper prices stayed fairly flat over the next four years, moving in a range of US$2.50 to US$3 per pound.

    20 year copper price performance.

    Chart via Macrotrends.

    The pandemic’s impact on mine supply and refined copper in 2020 pushed prices higher despite the economic slowdown. The copper price climbed from a low of US$2.17 in March to close out the year at US$3.52.

    In 2021, signs of economic recovery and supercharged interest in EVs and renewable energy pushed the price of copper to rally higher and higher. Copper topped US$4.90 per pound for the first time ever on May 10, 2021, before falling back to close at US$4.76.

    Also affecting the copper price at that time was expectations for higher copper demand amid supply concerns out of two of the world’s major copper producers: Chile and Peru. In late April 2021, port workers in Chile called for a strike, while in Peru presidential candidate Pedro Castillo proposed nationalizing mining and redrafting the country’s constitution.

    In early May 2021, news broke that copper inventories were at their lowest point in 15 years. Expert market watchers such as Bank of America commodity strategist Michael Widmer warned that further inventory declines into 2022 could lead to a copper market deficit.

    After climbing to start 2022 at US$4.52, the copper price continued to spike on economic recovery expectations and supply shortages to reach US$5.02 per pound on March 6. Throughout the first quarter, fears of supply chain disruptions and historically low stockpiles amid rising copper demand drove prices higher.

    However, copper prices pulled back in mid-2022 on worries that further COVID-19 lockdowns in China, as well as a growing mortgage crisis, would slow down construction and infrastructure activity in the Asian nation. Rising inflation and interest hikes by the Fed also placed downward pressure on a wide basket of commodities, including copper. By late July 2022, copper prices were trading down at nearly a two year low of around US$3.30.

    In the early months of 2023 the copper price was trading over the US$4 per pound level after receiving a helpful boost from continuing concerns about low copper inventories, signs of rebounding demand from China, and news about the closure of Peru’s Las Bambas mine, which accounts for 2 percent of global copper production.

    However, that boost turned to a bust in the second half of 2023 as China continued to experience real estate sector issues, alongside the economic woes of the rest of the world. The price of copper dropped to a low for the year of US$3.56 per pound in mid October.

    Elevated supply levels kept copper trading in the US$3.50 to US$3.80 range for much of Q1 2024 before experiencing strong gains that pushed the price of the red metal to US$4.12 on March 18.

    Those gains were attributed to in part to tighter copper concentrate supply following the closure of First Quantum Minerals’ Cobre Panama mine, guidance cuts from Anglo American (LSE:AAL,OTCQX:AAUKF) and declining production at Chile’s Chuquicamata mine. In addition, China’s top copper smelters announced production cuts after limited supply led to lower profits from treatment and refining charges.

    BHP’s (ASX:BHP,NYSE:BHP,LSE:BHP) attempted takeover of Anglo American also stoked fears of even tighter global copper mine supply. These supply-side challenges continued to juice copper prices in Q2 2024, causing a jump of nearly 29 percent from US$4.04 per pound on April 1 to a then all-time high of US$5.20 by May 20, 2024.

    What was the highest price for copper ever?

    The price of copper reached its highest recorded price of US$5.24 per pound, or US$11,552 per metric ton, on March 26, 2025. Earlier in the session, the red metal’s price had surged as high as US$5.37 before settling to its new all time high closing price. Read on to found out how the copper price reached those heights.

    Why did the copper price hit an all-time high in 2025?

    Copper started 2025 at US$3.99. Throughout the first quarter of 2025, copper prices were lifted by increasing demand from China’s economic stimulus measures, renewable energy and artificial intelligence (AI) technologies and stockpiling brought on by fear of US President Trump’s tariff threats.

    Trump has said the US is considering placing tariffs of up to 25 percent on all copper imports in a bid to spark increased domestic production of the base metal.

    In late February, he signed an executive order instructing the US Commerce Department to investigate whether imported copper poses a national security risk under Section 232 of the Trade Expansion Act of 1962.

    Looking at the bigger picture, copper’s rally in recent years has encouraged bullish sentiment on prices looking ahead. In the longer term, the fundamentals for copper are expected to get tighter as demand increases from sectors such as EVs and energy storage. A new report from the International Energy Forum (IEF) projects that as many as 194 new copper mines may need to come online by 2050 to support massive demand from the global energy transition.

    Looking over to renewable energy, according to the Copper Development Association, solar installations require about 5.5 MT of copper for every megawatt, while onshore wind turbines require 3.52 MT of copper and offshore wind turbines require 9.56 MT of copper.

    The rise of AI technology is also bolstering the demand outlook for copper. Commodities trader Trafigura has said AI-driven data centers could add one million MT to copper demand by 2030, reports Reuters.

    Where can investors look for copper opportunities?

    Copper market fundamentals suggest a return to a bull market cycle for the red metal in the medium-term. The copper supply/demand imbalance also presents an investment opportunity for those interested in copper-mining stocks.

    Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

    This post appeared first on investingnews.com

    Major offtake and funding deal to advance development and exploration activities

    American West Metals Limited (American West or the Company) ( ASX: AW1) is pleased to announce that the Company has entered into a binding agreement with global metal trading and advisory group Ocean Partners Holding Ltd (OP or Ocean Partners) which will comprise an equity investment in American West as well as project development funding and copper-silver offtake to OP for the Storm Copper Project.

    • US$3.5m Royalty funding brought forward. Taurus Mining Royalty has agreed to advance the US$3.5m second tranche of the Royalty payment based on the positive Storm PEA results, with payment of US$2.8m to be made to American West this month

    Dave O’Neill, American West’s Managing Director, said:

    “We are very pleased to announce a strategic partnership and funding package for the Storm Copper Project which secures the long-term future of the Project. This is another significant milestone for Storm and continues to position Storm as the next potential copper mine in Canada, joining other very successful base metal mines in the region such as Polaris (22Mt @ 14.1% Zn, 4% Pb) and Nanisivik (18Mt @ 9% Zn, 0.7% Pb)

    “American West’s ability to attract and partner with global companies like Ocean Partners speaks volumes to the high-quality of the Project and the management team, and emphasises the low-risk pathway to potential development.

    “Ocean Partners’ existing partnerships and experience with ore-sorting and direct shipping ore (DSO) copper products are a natural fit with Storm and will help strengthen and streamline the technical aspects of the processing work flow for the PFS and beyond.

    “On the back of the recently released Storm PEA, Taurus has agreed to advance the second tranche of the royalty payment. This tranche of funding will now be available immediately and demonstrates Taurus’ strong belief in the development and growth potential of Storm.

    “The funding package and strategic partnership will allow American West to execute the dual strategy of aggressive exploration and streamlined development during 2025. We look forward to updating investors as the work programs are finalised and get underway.”

    Brent Omland, Ocean Partners CEO, also commented:

    “We are delighted to be partnering with American West on the Storm Copper Project which is rapidly emerging as a long-life, district-scale copper opportunity. Our shared goal is the timely success of the Project and we look forward to working closely with the American West team as they continue to make significant advances through process innovation and resource growth. Ocean Partners has extensive experience in marketing and trading DSO into global markets and are confident in the marketability and attractiveness of the Storm copper-silver product.”

    Click here for the full ASX Release
    This post appeared first on investingnews.com